MS-Selfie Research

Updates on ground-breaking MS research that may have an impact on how you manage your MS in the future. This will include conference highlights and important MS-related events.

EBV immunotherapy for MS: glofitamab inductionListen now (23 min) | An induction-maintenance trial with glofitamab (antiCD20/CD3) in MS; induction to purge EBV from the peripheral compartment and a…
16
ECTRIMS 2022 - highlightsListen now (22 min) | My initial highlights from ECTRIMS 2022 in Amsterdam. It is all about flipping the pyramid and going beyond inflammatory disease…
29
More evidence that EBV causes MSListen now (22 min) | A good analogy for the adaptive immune system is the military analogy. In this newsletter I explain how the immune system targets…
54
Will an EBV vaccine work?Watch now (17 min) | A short talk I gave on EBV vaccination as a strategy to prevent and/or treat MS. Do you think it is feasible? What do we need to do…
45
EBV antivirals to treat MSListen now (12 min) | I need your help to test EBV antiviral drugs in MS. In this newsletter I explain the science behind the proposed studies. Do you…
61
The European Association of Neurology (EAN) meeting is my first face-2-face conference since March 2020.
22
Why is natalizumab not licensed to treat progressive MS? Listen now (13 min) | New data shows that natalizumab has an impact on chronic active lesions, including slowly expanding lesions, and indicates that…
66
See all